Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy

MLA

Nanwen Zhang, et al. “Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy.” Frontiers in Pharmacology, vol. 12, May 2021. EBSCOhost, https://doi.org/10.3389/fphar.2021.681424.

APA

Nanwen Zhang, Qingmei Zheng, Yaduan Wang, Juan Lin, He Wang, Rui Liu, Mengru Yan, Xiaofeng Chen, Juhua Yang, & Xiaole Chen. (2021). Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.681424

Chicago

Nanwen Zhang, Qingmei Zheng, Yaduan Wang, Juan Lin, He Wang, Rui Liu, Mengru Yan, Xiaofeng Chen, Juhua Yang, and Xiaole Chen. 2021. “Renoprotective Effect of the Recombinant Anti-IL-6R Fusion Proteins by Inhibiting JAK2/STAT3 Signaling Pathway in Diabetic Nephropathy.” Frontiers in Pharmacology 12 (May). doi:10.3389/fphar.2021.681424.